/PRNewswire/ Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) announced publication of an electronic poster at the CAR-TCR Summit Europe 2021 with data.
Palm Beach, FL –February 23, 2021 – In the breast cancer therapy market, the rise in the prevalence of cancer, has propelled the T-cell therapy market over the last few years and it is projected to continue to do so for several years to come. T-cell therapy includes using genetically engineered T-cells to produce an artificial T-cell receptor for applications in immunotherapy. Growing prevalence of cancer across the world and increase in cancer research & development drive the market. According to the WHO, the number of global cancer deaths is projected to increase by 45% between 2008 and 2030. It is also estimated that by 2030, approximately 10 to 11 million cases of cancers would be diagnosed each year in low- and middle-income countries. The increase in investment in adoptive T-cell transfer approaches of disease treatment drives and the increasing number of clinical trials the market. Furthermore, technological advancements in manufacturing processes and developments in CAR
Oncolytics Biotech Reports Preclinical Data Demonstrating the Synergistic Anti-cancer Activity of Pelareorep Combined with CAR T Cell Therapy in Solid Tumors
42% (3/7) These very exciting data demonstrate pelareorep s ability to overcome major shortcomings of CAR T cells, said Dr. Matt Coffey, President and Chief Executive Officer of Oncolytics Biotech Inc. Despite commercial success in
hematological cancers, CAR T therapies have limited efficacy against solid tumors due to immunosuppressive tumor microenvironments (TMEs) that promote T cell exhaustion and exclusion. Pelareorep s ability to reverse immunosuppressive TMEs has been well documented in the clinic, and combining CAR T cells with pelareorep may enable their success against
Oncolytics Biotech® Reports Preclinical Data Demonstrating the Synergistic Anti-cancer Activity of Pelareorep Combined with CAR T Cell Therapy in Solid Tumors prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
ESPN SportsCenter Anchor, Hannah Storm to Headline Summit
ORLANDO, FL (February 4, 2021) Gainbridge and Versant Health are thrilled to announce the speaker lineup for the 2021 Women’s Leadership Summit presented by Versant Health to be hosted virtually February 24, 2021 at 1pm EST. In its second year at the Gainbridge LPGA, the Women’s Leadership Summit is pleased to welcome ESPN SportsCenter Anchor, Hannah Storm as the featured speaker.
Hannah Storm is a pioneer in sports and go-to journalist to host major events. She is also the founder of an all-female run production company, Brainstormin Productions, that celebrates women s accomplishments in the sports industry and also develops documentaries, short films and branded content for a variety of networks. In 2018, Storm made history as being part of the first female duo to call an NFL game as member of Amazon Prime Video’s Thursday Night Football broadcast.